Upadacitinib and its role in the treatment of vitiligo: a new possible therapeutic perspective

Published: 13 February 2024| Version 1 | DOI: 10.17632/fjvjfp7k7w.1
Contributors:
Jorge Magdaleno-Tapial,
,
, Rodrigo Peñuelas-Leal, Carolina Labrandero-Hoyos, José Luis Sánchez-Carazo, Amparo Pérez-Ferriols

Description

Supplemental Table 1. Clinico-epidemiological characteristics of patients with vitiligo who received upadacitinib.

Files

Categories

Vitiligo

Licence